Search Results

There are 38111 results for: content related to: Late (Complicated) Parkinson's Disease

  1. Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

    Drug Development Research

    Volume 42, Issue 1, September 1997, Pages: 1–25, Jasper Dingemanse

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-2299(199709)42:1<1::AID-DDR1>3.0.CO;2-I

  2. Early (Uncomplicated) Parkinson's Disease

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Pages: 217–236, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch14

  3. You have free access to this content
    Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 5–15, J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli and W. H. Oertel

    Version of Record online : 22 DEC 2012, DOI: 10.1111/j.1468-1331.2012.03866.x

  4. Tolcapone, a Selective Catechol-O-Methyltransferase Inhibitor for Treatment of Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 1, January-February 1999, Pages: 6–20, David R. P. Guay

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.1.6.30516

  5. Catechol-O-Methyltransferase (COMT) Inhibitors in Parkinson's Disease

    Journal of the American Geriatrics Society

    Volume 48, Issue 6, June 2000, Pages: 692–698, Cheryl Waters

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.2000.tb04732.x

  6. Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 6, June 2000, Pages: 610–620, Karin Jorga, Ludger Banken, Bärbel Fotteler, Paul Snell and Jean-Louis Steimer

    Version of Record online : 15 JUN 2000, DOI: 10.1067/mcp.2000.106795

  7. Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly

    Clinical Pharmacology & Therapeutics

    Volume 62, Issue 3, September 1997, Pages: 300–310, Karin M. Jorga, Grzegorz Se̹dek, Bärbel Fotteler, Gerhard Zürcher, Thorkild Nielsen and John W. Aitken

    Version of Record online : 22 SEP 1997, DOI: 10.1016/S0009-9236(97)90033-3

  8. Late (Complicated) Parkinson's Disease

    European Handbook of Neurological Management

    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio, Pages: 245–265, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch18

  9. COMT inhibitors

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S45–S51,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5560

  10. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Version of Record online : 20 SEP 2001, DOI: 10.1002/mds.1175

  11. Interventions to Achieve Tonic Exposure to Levodopa: Delaying or Preventing the Onset of Motor Complications

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 11P2, November 1999, Pages: 169S–179S, Mark S. Luer

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.17.169S.30886

  12. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  13. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Version of Record online : 21 OCT 2014, DOI: 10.1002/mds.26050

  14. You have free access to this content
    Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1739–1752, M J Bonifácio, L Torrão, A I Loureiro, P N Palma, L C Wright and P Soares-da-Silva

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bph.13020

  15. Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 820–826, D. Nyholm, A. Johansson, H. Lennernäs and H. Askmark

    Version of Record online : 5 DEC 2011, DOI: 10.1111/j.1468-1331.2011.03614.x

  16. You have free access to this content
    Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

    British Journal of Clinical Pharmacology

    Volume 40, Issue 3, Sep 1995, Pages: 253–262, J. Dingemanse, K. Jorga, G. Zurcher, M. Schmitt, G. Sedek, M. Da Prada and P. Van Brummelen

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1995.tb05781.x

  17. Tolcapone added to levodopa in stable parkinsonian patients: A double-blind placebo-controlled study

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 928–934, Dr. Erik Dupont, Jean-Marc Burgunder, Leslie J. Findley, Jan-Edvin Olsson and Ernest Dorflinger

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870120615

  18. Early (Uncomplicated) Parkinson's Disease

    European Handbook of Neurological Management

    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio, Pages: 224–244, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch17

  19. Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial

    European Journal of Neurology

    Volume 4, Issue 4, July 1997, Pages: 333–341, V. V. Myllylä, M. Jackson, J. P. Larsen, H. Baas and Tolcapone International Parkinson's Disease Study (TIPS) Group I

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1468-1331.1997.tb00358.x

  20. The effect of tolcapone on the pharmacokinetics of benserazide

    European Journal of Neurology

    Volume 6, Issue 2, March 1999, Pages: 211–219, Karin M. Jorga, Jan P. Larsen, Antonie Beiske, Michael Schleimer, Bärbel Fotteler, Monique Schmitt and Brit Moe

    Version of Record online : 27 JUL 2007, DOI: 10.1111/j.1468-1331.1999.tb00015.x